CRWD surged 13.85%, not because of financial reports
A single call to "slow down AI" ignited cybersecurity, pushing CrowdStrike with a 45x price-to-sales ratio to $241 billion
Analyst-grade AI deep-dives on US stocks — thesis, valuation, risks and catalysts. Updated as new reports publish.
A single call to "slow down AI" ignited cybersecurity, pushing CrowdStrike with a 45x price-to-sales ratio to $241 billion
UBS downgraded its worst single day of the year, with NuScale holding $1.9 billion in cash but still not holding a single binding commercial contract.
First criticality, Meta's 1.2 GW large order, NRC approval, yet the stock price fell back to $43
Quarterly revenue of 96.2 billion yuan, price-to-earnings ratio of only 27.88 times, and a market value of 5.33 trillion yuan, is the flip side of peak gross margin and diversion of self-developed development
The contract book and the market cap are both $1.7 billion, and the 2027 exit run-rate decides whether that money is worth anything.
A single quarterly free cash outflow of $6.58 billion was equivalent to 45% growth in AI clouds. Is this deal worth it?
The first mRNA cancer vaccine successfully achieved phase III, growing its market value to $45 billion overnight, though detailed data has yet to be released
Growth is accelerating, but valuations are not outrageous; the real suspense for NVDA lies in August 26
A beat plus above-consensus guidance still ended in an 8.4% one-day drop: part of the growth is pricing, gross margin is heading down, and the stock is worth owning over quarters but not chasing this week.
Revenue grew 25% and margins hit an all-time high, yet the market fixated on one line about next quarter's flat gross margin — worth owning for the long run, not worth chasing this week.
Demand is real and the unit economics work, but 22x EV/ARR is three times what the peer group trades at — a name to follow on a long horizon while the short-term money sits elsewhere.
Revenue nearly doubled and the AI segment turned profitable for the first time, but the company spent $18.4B on capex in a single quarter while its cloud backlog stands at one-seventh of CoreWeave's.
The evidence behind 93% growth and a 62% margin is real, but 50.9x EV/Sales already prepays the story out to 2030 — a long-term hold worth tracking, with a price that has run ahead of the money.
The fundamentals picked LITE out of the crowd, the money flows have not yet given a timing signal, and the valuation has squeezed the remaining room very thin — so the call right now is to wait for conditions.
The fastest-growing AVGO and NVDA have underperformed their sectors by nearly 40 percentage points year-to-date, while INTC, whose growth rate has not been disclosed, has risen 170%. The market bought narrative purity and sold profit momentum.
Revenue doubled and losses narrowed, yet it could not avoid the dual shadow of 911.5 million shares unlocking and $18.37 billion in capital expenditure
Silicon Photonics annualized 680 million, with a 2028 target of 3.6 billion, but the market has already cashed in on the positive news
Q2 revenue surged 93% and net retention reached 157%, but a 47.8x price-to-sales ratio has already sealed the victory of 2028
The optical module market leader rose 9.24% in a single day, but the real test was in the August 11 earnings report
AWS accelerated to 37%, profits doubled, but free cash flow turned negative—the market applauded first
The record-breaking earnings delivered on a turning point, but only made up for a small part of the crash, with valuations still betting on 2027
Behind the strongest single-day record in 18 years are Azure breaking 100 billion yuan and free cash flow dropping to 67 billion yuan
A revenue gap of 140 million triggered a sharp drop, with guidance raised simultaneously with a 22.6% profit margin—the market is selling on rhythm
Despite earnings reports exceeding expectations across the board, it dropped 20% in a single day. The real repricing is the AI capacity gamble supported by $2.5-3 billion in capital investment.